Page 195 - Materials Chemistry, Second Edition
P. 195

176                         Life Cycle Assessment of Wastewater Treatment



                      References  Langford et al.   (2011)  Radjenović et al.   (2009a)  Seira et al. (2013)  Göbel et al.   (2005)  Nieto et al. (2007)  (Continued)





                   Limits of   Detection   (ng g−1 d.w.)  2–20  0.44–89.2 a  0.44–89.2 a  2.10–96.3 a  2.5–74  14–15 a  14–32 a

                 Overview of Analytical Methods for the Determination of Pharmaceutical Compounds in Sewage Sludge
                     Recoveries   (%)  >76  36.8–130  33.5–122  29.2–102  92–110  51–64  72–109




                     Analytical   Determination  LC-MS/MS  LC-MS/MS  LC-MS/MS  LC-MS/MS  LC/MS




                      Clean-up             SPE (Oasis   HLB)  SPE (Oasis   MAX)  SPE (Oasis   HLB)

                         —                                           —

                   Total   Solvent   Volume  n.d.  22 mL  15 mL  22 mL  40 mL




                      Extraction Solvents  MeOH or MeOH:formic acid   (100:0.1, v/v) (70 °C)  MeOH:water (2:1, v/v)  (100 °C)  MeOH:water (65:35, v/v)  (100 °C)  MeOH:water (1:1, v/v)  (100 °C)  MeOH:phosphoric acid   50 mM (1:1, v/v) (80 °C)







                     Extraction   Technique

                         PLE               PLE            PLE  PLE   PLE

                     Sample   Amount  1–10 g  1 g         0.35 g  0.2 g  5 g
              TABLE 9.1 (CONTINUED)  Sample Therapeutic Group  Sludge Anti-inflammatory   drugs, antibiotics,   anti-epileptics,   β-blocker,   antidepressants,   H2 receptor   agonists, nervous   stimulants, lipid   regulators, and   others (the top 30   dispensed in   Scotland)  Primary  Anti-inflammatory   sludge drugs, antibiotics,   β-blocker, n
   190   191   192   193   194   195   196   197   198   199   200